/   Home   /   Newsroom   /   Research News

Scientists Discover Mogrosides Synthesis Pathway and Its Anti-tumor Effect

May 23, 2016     Email"> PrintText Size

Siraitia grosvenorii is a traditional Chinese medicinal plant that is principally cultivated in Guangxi Province of China. Fruits of S. grosvenorii have been used for thousands of years as a natural sweetener, and as folk medicine for treating lung congestion, colds, pharyngitis, constipation and acute bronchitis in the Chinese Pharmacopoeia. Mogrosides, the major active constituents of S. grosvenorii, are a mixture of cucurbitane-type triterpenoid glycosides that have been proven to be powerful and zero-caloric sweeteners. They can hence be used as a sucrose substitute for diabetic and obese patients. Therefore, it is necessary to discover the mogrosides synthesis-related pathway and study its physiological effect such as anti-tumor. 

The Laboratory of Functional Sugar and Natural Bioactive Products led by Dr. SUN Yuanxia at Tianjin Institute of Industrial Biotechnology (TIB) of Chinese Academy of Sciences successfully identified a multifunctional P450 (CYP87D18). When it was co-expressed with cucurbitadienol synthase (SgCbQ) and cytochrome reductase (CPR) in yeast, three key compounds 11-oxo cucurbitadienol, 11-hydroxy cucurbitadienol and 11-oxo-24, 25-epoxy cucurbitadienol were obtained and confirmed by Nuclear Magnetic Resonance (NMR) analysis. The results obtained help to understand the order of cyclization, glycosylation, and esterification reactions during the mogrosides synthesis pathway. 

This group meanwhile purified the compounds mogrol and mogroside V and tested their anti-tumor effect. They discovered that mogroside V possessed tumor growth inhibitory activity in models of pancreatic cancer by promoting apoptosis and inhibiting proliferation and survival of pancreatic cancer cells. Moreover, mogroside V could increase survival of the mice, indicating that this natural compound might possess potential therapeutic activity and could be used for daily consumption as an additive in foods and drinks to prevent or treat pancreatic cancer. Given that mogroside V is a natural sweetener that has been approved by the United States Food and Drug Administration, those results will help to screen new anti-tumor drug and promote the higher potential application of Siraitia grosvenorii. 

This work was supported by National High Technology Research and Development Program of China. The papers have been published in journals of American Journal of Cancer Research, Plant & Cell Physiology, and Oncogenesis.


(Editor: LIU Jia)

Related Articles

tumor;nanoparticle;drug delivery;deoxygenation

Study Shows that Nanoparticles Serve as a Good Tumor Deoxygenation Agent

Jan 23, 2017

A group of researchers from the Shanghai Institute of Ceramics, Chinese Academy of Sciences and the East China Normal University have developed a deoxygenation agent using polyvinyl pyrrolidone modified Mg2Si nanoparticles. This agent is pH sensitive, efficiently consumes...


Inhibition of Human Copper Trafficking Attenuates Tumor Growth

Nov 09, 2015

Prof. JIANG Hualiang’s group from Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences, Prof. HE Chuan’s group from Chicago University and Prof. Jing Chen's group from Emory University using computational and experimental approaches identified a se...

Contact Us

  • 86-10-68597521 (day)
    86-10-68597289 (night)
  • 86-10-68511095 (day)
    86-10-68512458 (night)
  • cas_en@cas.cn
  • 52 Sanlihe Rd., Beijing,
    China (100864)

Copyright © 2002 - Chinese Academy of Sciences